Insider · CIK 0001458643

Chaudhuri Bhaskar

CIK 0001458643 Name as filed on the most recent filing

Filed as Chaudhuri Bhaskar (19)

25 transaction lines · from 19 filings · filed 2009-04-21 to 2021-06-28 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

25 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2021-06-25 S, Open-market sale Arcutis Biotherapeutics, Inc.ARQT 185,763, disposed Open Form 4 filing 0001567619-21-012655
2021-06-24 S, Open-market sale Arcutis Biotherapeutics, Inc.ARQT 20,048, disposed Open Form 4 filing 0001567619-21-012655
2021-06-21 S, Open-market sale Arcutis Biotherapeutics, Inc.ARQT 69,190, disposed Open Form 4 filing 0001567619-21-012548
2021-06-01 S, Open-market sale Arcutis Biotherapeutics, Inc.ARQT 275,000, disposed Open Form 4 filing 0001567619-21-011610
2021-04-20 S, Open-market sale Arcutis Biotherapeutics, Inc.ARQT 2 lines 280,568, disposed Open Form 4 filing 0001567619-21-010739
2021-04-20 S, Open-market sale Arcutis Biotherapeutics, Inc.ARQT 2 lines 280,568, disposed Open Form 4 filing 0001567619-21-008502
2021-03-22 S, Open-market sale Arcutis Biotherapeutics, Inc.ARQT 2 lines 311,021, disposed Open Form 4 filing 0001567619-21-006825
2021-02-22 S, Open-market sale Arcutis Biotherapeutics, Inc.ARQT 2 lines 355,191, disposed Open Form 4 filing 0001567619-21-004762
2021-02-01 S, Open-market sale Arcutis Biotherapeutics, Inc.ARQT 330,804, disposed Open Form 4 filing 0001567619-21-002041
2021-01-29 S, Open-market sale Arcutis Biotherapeutics, Inc.ARQT 1,403, disposed Open Form 4 filing 0001567619-21-002041
2019-06-03 P, Open-market purchase Teligent, Inc.TLGT 7,005, acquired Open Form 4 filing 0001144204-19-029688
2009-11-20 P, Open-market purchase Valeant Pharmaceuticals InternationalVRX 99,928, acquired Open Form 4 filing 0001209499-09-000105
2009-11-18 P, Open-market purchase Valeant Pharmaceuticals InternationalVRX 80,097, acquired Open Form 4 filing 0001209499-09-000103
2009-11-10 P, Open-market purchase Valeant Pharmaceuticals InternationalVRX 50,039, acquired Open Form 4 filing 0001209499-09-000099
2009-08-14 P, Open-market purchase Valeant Pharmaceuticals InternationalVRX 90,026, acquired Open Form 4 filing 0001209499-09-000072
2009-05-26 P, Open-market purchase Valeant Pharmaceuticals InternationalVRX 30,001, acquired Open Form 4 filing 0001209499-09-000038
2009-05-18 P, Open-market purchase Valeant Pharmaceuticals InternationalVRX 30,002, acquired Open Form 4 filing 0001209499-09-000036
2009-05-11 P, Open-market purchase Valeant Pharmaceuticals InternationalVRX 29,991, acquired Open Form 4 filing 0001209499-09-000016
2009-05-04 P, Open-market purchase Valeant Pharmaceuticals InternationalVRX 30,008, acquired Open Form 4 filing 0001209499-09-000012
2009-04-27 P, Open-market purchase Valeant Pharmaceuticals InternationalVRX 29,998, acquired Open Form 4 filing 0001209499-09-000010
2009-04-20 P, Open-market purchase Valeant Pharmaceuticals InternationalVRX 30,007, acquired Open Form 4 filing 0001209499-09-000008

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 11
  • Open-market sale 14
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. CHAUDHURI BHASKAR, insider transactions. Retrieved 2026-08-24 from https://ebomi.com/insider/0001458643

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.